Sensorion sets investor webcast for SENS — 601 gene therapy program update
Sensorion will host an SENS-601 Program Day on Sept. 22, 2026, starting 2:30 p.m. CET (8:30 a.m. ET). Event will outline the SENS-601 gene therapy program for GJB2-related hearing loss, including the HearConnex trial design and endpoints. Management will present alongside external speakers Christine Petit and Sharon Cu